Xvivo Perfusion AB | Cash Flow
Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
10,718.00
6,716.00
7,398.00
2,993.00
7,452.00
17,497
Depreciation, Depletion & Amortization
1,415.00
4,726.00
11,638.00
13,218.00
14,917.00
6,766
Other Funds
-
216.00
1,468.00
-
-
9,934
Funds from Operations
11,732.00
6,790.00
15,470.00
13,192.00
17,978.00
34,197
Changes in Working Capital
1,732.00
10,531.00
6,892.00
642.00
4,212.00
10,570
Net Operating Cash Flow
13,464.00
3,741.00
8,578.00
12,550.00
22,190.00
23,627
Capital Expenditures
12,590.00
14,968.00
13,209.00
20,512.00
34,934.00
Sale of Fixed Assets & Businesses
-
-
-
329.00
-
Purchase/Sale of Investments
2,262.00
393.00
1,081.00
-
71.00
Net Investing Cash Flow
14,852.00
15,361.00
14,290.00
29,725.00
35,523.00
Issuance/Reduction of Debt, Net
2,430.00
6,658.00
-
-
-
Net Financing Cash Flow
2,303.00
62,697.00
1,468.00
244.00
184,798.00
Net Change in Cash
3,645.00
44,072.00
6,969.00
16,363.00
170,450.00
Free Cash Flow
13,081.00
4,124.00
1,466.00
3,936.00
16,566.00
Net Assets from Acquisitions
-
-
-
9,542.00
518.00
Change in Capital Stock
127.00
69,139.00
-
244.00
184,798.00
Exchange Rate Effect
46.00
477.00
211.00
568.00
1,015.00
About Xvivo Perfusion AB
View Profile
